• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性间皮瘤的病理诊断:时间线展望以及相关建议和指南的出现

Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines.

作者信息

Ascoli Valeria

出版信息

Ann Ist Super Sanita. 2015;51(1):52-9. doi: 10.4415/ANN_15_01_09.

DOI:10.4415/ANN_15_01_09
PMID:25857384
Abstract

Malignant mesothelioma (MM) is rare and difficult to diagnose. Its identification depends upon pathological investigation (cyto-histological assessment and immunohistochemistry) supported by clinical and radiological evidence. In the last decade, the standardization of diagnostic methods has become a major focus of debate among pathologists and clinicians. This has led to the writing of guidelines and recommendation for the diagnosis to achieve the goal of a standard diagnosis. In this article, a chronological view relating to the pathological diagnosis of MM is presented together with a review of guidelines and recommendations.

摘要

恶性间皮瘤(MM)较为罕见且难以诊断。其确诊依赖于病理检查(细胞组织学评估和免疫组织化学),并需临床和影像学证据支持。在过去十年中,诊断方法的标准化已成为病理学家和临床医生争论的焦点。这促使人们撰写诊断指南和建议,以实现标准化诊断的目标。本文呈现了与MM病理诊断相关的时间线观点,并对指南和建议进行了综述。

相似文献

1
Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines.恶性间皮瘤的病理诊断:时间线展望以及相关建议和指南的出现
Ann Ist Super Sanita. 2015;51(1):52-9. doi: 10.4415/ANN_15_01_09.
2
Pathology reporting of malignant pleural mesothelioma first diagnosis: A population-based approach.恶性胸膜间皮瘤首次诊断的病理报告:基于人群的方法。
Pathol Res Pract. 2016 Oct;212(10):886-892. doi: 10.1016/j.prp.2016.07.010. Epub 2016 Jul 22.
3
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Feb;33(2):129-142. doi: 10.1016/j.annonc.2021.11.005. Epub 2021 Nov 30.
4
On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).关于恶性胸膜间皮瘤的诊断:一项基于尸检的171例病例研究(1997 - 2016年)
Tumori. 2019 Aug;105(4):359-360. doi: 10.1177/0300891618820012. Epub 2018 Dec 20.
5
Prognostic factors in malignant pleural mesothelioma.恶性胸膜间皮瘤的预后因素
Hum Pathol. 2015 Jun;46(6):789-804. doi: 10.1016/j.humpath.2015.02.006. Epub 2015 Feb 28.
6
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.恶性胸膜间皮瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2015 Sep;26 Suppl 5:v31-9. doi: 10.1093/annonc/mdv199. Epub 2015 Jul 28.
7
On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).关于恶性胸膜间皮瘤的诊断:一项基于尸检的171例病例研究(1997 - 2016年)
Tumori. 2019 Aug;105(4):361-362. doi: 10.1177/0300891618820007. Epub 2018 Dec 28.
8
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.恶性间皮瘤病理诊断指南:国际间皮瘤兴趣小组共识声明的 2012 年更新。
Arch Pathol Lab Med. 2013 May;137(5):647-67. doi: 10.5858/arpa.2012-0214-OA. Epub 2012 Aug 28.
9
Perineural spread of malignant mesothelioma with spinal intramedullary involvement.恶性间皮瘤的神经周围扩散伴脊髓髓内受累。
Clin Neurol Neurosurg. 2014 May;120:116-9. doi: 10.1016/j.clineuro.2014.03.005. Epub 2014 Mar 13.
10
Two malignancies or an unusual presentation of a pleural malignancy?两种恶性肿瘤还是胸膜恶性肿瘤的不常见表现?
Lung Cancer. 2013 Aug;81(2):306-7. doi: 10.1016/j.lungcan.2013.04.002. Epub 2013 May 17.

引用本文的文献

1
Ascites as a Rare Manifestation of Malignant Peritoneal Mesothelioma: A Case Report.腹水作为恶性腹膜间皮瘤的罕见表现:一例报告
Cureus. 2024 Oct 7;16(10):e70982. doi: 10.7759/cureus.70982. eCollection 2024 Oct.
2
Dissecting and Reconstructing Matrix in Malignant Mesothelioma Through Histocell-Histochemistry Gradients for Clinical Applications.通过组织细胞 - 组织化学梯度剖析和重建恶性间皮瘤中的基质用于临床应用
Front Med (Lausanne). 2022 Apr 13;9:871202. doi: 10.3389/fmed.2022.871202. eCollection 2022.
3
Incidence, Survival Analysis and Future Perspective of Primary Peritoneal Mesothelioma (PPM): A Population-Based Study from SEER Database.
原发性腹膜间皮瘤(PPM)的发病率、生存分析及未来展望:一项基于监测、流行病学和最终结果(SEER)数据库的人群研究
Cancers (Basel). 2022 Feb 14;14(4):942. doi: 10.3390/cancers14040942.
4
An integrative histopathologic clustering model based on immuno-matrix elements to predict the risk of death in malignant mesothelioma.基于免疫矩阵元素的综合组织病理学聚类模型预测恶性间皮瘤的死亡风险。
Cancer Med. 2020 Jul;9(13):4836-4849. doi: 10.1002/cam4.3111. Epub 2020 May 11.
5
Diagnosis of mesothelioma with deep learning.利用深度学习诊断间皮瘤。
Oncol Lett. 2019 Feb;17(2):1483-1490. doi: 10.3892/ol.2018.9761. Epub 2018 Nov 26.
6
Clustering of malignant pleural mesothelioma in asbestos factories: a subgroup analysis in a 29-year follow-up study to identify high-risk industries in Taiwan.石棉工厂中恶性胸膜间皮瘤的聚集:一项 29 年随访研究中的亚组分析,以确定台湾的高危行业。
BMJ Open. 2018 Dec 9;8(12):e021063. doi: 10.1136/bmjopen-2017-021063.
7
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.CD44及其配体透明质酸作为恶性胸膜间皮瘤潜在生物标志物:证据与展望
Respir Res. 2017 Apr 12;18(1):58. doi: 10.1186/s12931-017-0546-5.
8
The Role of CD90 in the Differential Diagnosis of Pleural Malignant Mesothelioma, Pulmonary Carcinoma and Comparison with Calretının.CD90在胸膜恶性间皮瘤、肺癌鉴别诊断中的作用及与钙视网膜蛋白的比较
Pathol Oncol Res. 2017 Jul;23(3):487-491. doi: 10.1007/s12253-016-0135-9. Epub 2016 Oct 19.